June 2025 LabCoP Extended ECHO session: Making Genomics Work for TB: Practical and Cost-Effective Use of tNGS in TB Programs
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
May 2025 LabCoP Extended Echo Session. Closing the gap in drug-resistant TB diagnosis: the critical role of sequencing
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
May 2025 LabCoP Extended ECHO Session: Experiences, challenges and lessons learnt in improving the public health laboratories surveillance capabilities for priority diseases The experiences of Burkina Faso, and São Tomé and Príncipe
In this ECHO session,São Tomé and Príncipe, and Burkina Faso shares their experiences, challenges, lessons learnt and priority areas in improving detection, surveillance and res
April 2025 LabCoP M&E ECHO Session: Improving results utilization towards UNAIDS 95-95-95 using Results Framework: The Uganda Experience
In this session the Ministry of Uganda, shares their experiences on how they have used HIV Action Plan Results Framework to track progress towards achieving the UNAIDS performance
March 2025 LabCoP ECHO Session: Stool-based testing in the era of childhood TB diagnosis: current status and country experience
Following the WHO recommendation in 2022, stool-based testing has been introduced globally, with particular success in several African countries. In this session, presented by Mans
October 2024 LabCoP Extended ECHO Session on 03 October: Improving Lab Performance through KPI Management of Service-Level Agreements
In this second session in a series delivered by USAID and GHSC-PSM to ASLM’s Laboratory System Strengthening community of practice, we shared PEPFAR’s experience in establishin
October 2024 LabCoP ECHO Session on 17 October: Optimizing the use of GeneXpert® System
Regular maintenance, repair and effective monitoring are some of the aspects known to increased utilization of medical laboratory testing platforms. In this session, presented by E
October 2024 AMR CoP ECHO Session: The EUCAST system and EUCAST clinical breakpoints
In this Antimicrobial (AMR) Community of Practice (CoP) webinar on 11 October 2024, we focus on the European Committee on Antimicrobial Susceptibility Testing (EUCAST), tracing its
LabCoP Mpox Special ECHO Session #01: Epidemiology, Recent Trends, and the Current Diagnostic Landscape in Supporting the Mpox Response
On 29 August 2024, ASLM’s LabCoP hosted the first session in a series of special ECHO sessions that focuses on mpox, epidemiology, recent trends, and the current diagnostic lands